Nicorette Invisi (Nicotine)

Nicotine, the active ingredient in Nicorette Invisi, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It is intended for adult smokers who are seeking to quit, providing a controlled release of nicotine to lessen withdrawal symptoms and cravings associated with smoking cessation. The patch delivers nicotine through the skin over several hours, helping to maintain steadier blood nicotine levels compared with smoking.

GNH USA supplies Nicorette Invisi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicorette Invisi is a nicotine replacement therapy used in smoking cessation. - Smoking cessation: reduces cravings and withdrawal symptoms in adults attempting to quit smoking. - Tobacco dependence: supports gradual reduction of nicotine intake for habitual tobacco users. - Relapse prevention: helps maintain abstinence by providing steady nicotine levels during the critical early quitting period.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Sleep disturbances: insomnia or vivid dreams, especially when the patch is worn overnight. - Gastrointestinal discomfort: nausea or mild stomach upset.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Cardiovascular events: chest pain, rapid heartbeat, or hypertension. - Severe skin reaction: blistering or dermatitis extending beyond the patch area.

Precautions should be observed when using Nicorette Invisi. - Cardiovascular assessment: evaluate patients with recent heart disease before initiating therapy. - Pregnancy and lactation: avoid use unless benefits outweigh potential risks; data are limited. - Concomitant nicotine products: do not use other nicotine replacement therapies simultaneously. - Children safety: keep patches out of reach of children to prevent accidental exposure. - Storage: Store at room temperature: keep in the original pouch, protect from moisture and direct heat.

Potential drug interactions must be considered. Major Interactions (Avoid): - Other nicotine replacement therapies: risk of nicotine overdose. - Beta‑blockers or other cardiovascular drugs: nicotine may mask tachycardia. - CYP2A6 inhibitors (e.g., methoxsalen): may increase nicotine plasma levels.

Moderate Interactions (Monitor Closely): - Alcohol: may amplify nicotine‑related side effects such as dizziness. - Caffeine: can increase jitteriness or insomnia when combined with nicotine. - Selective serotonin reuptake inhibitors (SSRIs): monitor for heightened anxiety or agitation.